Prescription of Direct Oral Anticoagulant Affects Activated Clotting Time During Percutaneous Coronary Intervention and Bleeding Events
Not Applicable
- Conditions
- Coronary artery disease
- Registration Number
- JPRN-UMIN000047650
- Lead Sponsor
- Tokyo women medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 246
Inclusion Criteria
Not provided
Exclusion Criteria
Patients receiving warfarin at the time of percutaneous coronary intervention (PCI) and patients whose activated clotting time was not measured at the time of PCI initiation were excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method